HIMS – Hims & Hers Health, Inc.

HIMS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

8.79

Margin Of Safety %

Put/Call OI Ratio

0.58

EPS Next Q Diff

-0.09

EPS Last/This Y

-1.34

EPS This/Next Y

0.92

Price

19.64

Target Price

8.15

Analyst Recom

2.4

Performance Q

Upside

N/A

Beta

Ticker: HIMS

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-15	HIMS	29.4	0.65	0.44	844774
2026-10-16	HIMS	27.96	0.64	0.44	873192
2026-10-19	HIMS	28.24	0.64	0.37	722862
2026-10-20	HIMS	29.23	0.63	0.43	740623
2026-10-21	HIMS	29.19	0.62	0.51	761464
2026-10-22	HIMS	29.09	0.61	0.67	771203
2026-10-23	HIMS	27.7	0.62	0.40	778171
2026-10-26	HIMS	27.55	0.65	0.53	731595
2026-10-27	HIMS	27.9	0.65	0.50	747580
2026-10-28	HIMS	29.4	0.64	0.22	759352
2026-10-29	HIMS	29.67	0.62	0.37	782337
2026-10-30	HIMS	27.68	0.61	0.29	795839
2026-11-02	HIMS	25.23	0.63	0.56	741807
2026-11-03	HIMS	25.73	0.63	0.41	764845
2026-11-04	HIMS	26.66	0.63	0.49	772416
2026-11-05	HIMS	23.85	0.62	0.54	780621
2026-11-06	HIMS	25.95	0.63	0.35	780579
2026-11-09	HIMS	22.9	0.62	0.69	744721
2026-11-10	HIMS	19.04	0.64	0.62	828722
2026-11-11	HIMS	20.77	0.62	0.62	879691
2026-11-12	HIMS	19.75	0.61	0.89	888294
2026-11-13	HIMS	19.74	0.58	0.65	892204
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-15	HIMS	29.39	-45.4	247.9	-0.56
2026-10-16	HIMS	28.05	-45.4	242.1	-0.56
2026-10-19	HIMS	28.16	-45.4	246.1	-0.56
2026-10-20	HIMS	28.16	-45.4	246.1	-0.56
2026-10-21	HIMS	29.19	-45.4	249.2	-0.56
2026-10-22	HIMS	29.12	-45.4	245.6	-0.56
2026-10-23	HIMS	27.69	-45.4	241.8	-0.56
2026-10-26	HIMS	27.58	-45.4	245.5	-0.56
2026-10-27	HIMS	27.92	-45.4	246.9	-0.56
2026-10-28	HIMS	29.36	-45.4	251.2	-0.56
2026-10-29	HIMS	29.70	-45.4	246.9	-0.56
2026-10-30	HIMS	27.68	-45.4	240.3	-0.56
2026-11-02	HIMS	25.24	-45.4	238.6	-0.56
2026-11-03	HIMS	25.73	-45.4	243.0	-0.56
2026-11-04	HIMS	26.75	-45.4	249.2	-0.56
2026-11-05	HIMS	23.85	-45.4	237.2	-0.56
2026-11-06	HIMS	26.00	-45.4	252.4	-0.56
2026-11-09	HIMS	22.94	-45.4	236.2	-0.56
2026-11-10	HIMS	19.14	-45.4	232.5	-0.56
2026-11-11	HIMS	20.81	-45.4	330.6	-0.56
2026-11-12	HIMS	19.72	-18.0	319.8	-0.77
2026-11-13	HIMS	19.64	-18.0	323.5	-0.77
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

Last Quarter Act. EPS

0.03

Avg. EPS Est. Current Quarter

-0.03

Avg. EPS Est. Next Quarter

-0.06

Insider Transactions

3.89

Institutional Transactions

10.15

Beta

Average Sales Estimate Current Quarter

891

Average Sales Estimate Next Quarter

904

Fair Value

20.65

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

73.1

Max Drawdown 5-Year %

-78.9

Target Price

8.15

P/E

Forward P/E

PEG

P/S

3.05

P/B

3.45

P/Free Cash Flow

EPS

-0.41

Average EPS Est. Cur. Y

-0.77

EPS Next Y. (Est.)

0.15

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-22.2

Relative Volume

0.79

Return on Equity vs Sector %

-80.1

Return on Equity vs Industry %

-60.4

EPS 1 7Days Diff

-0.2

EPS 1 30Days Diff

-0.21

EBIT Estimation

323.5

No data found for HIMS

HIMS — P/E HistoricalHousehold & Personal Products

Hims & Hers Health, Inc.

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 2442

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. The company was formerly known as Hims, Inc. and changed its name to Hims & Hers Health, Inc. in January 2021. The company was founded in 2017 and is based in San Francisco, California.

HIMS

Latest News

—

Caricamento notizie per HIMS…

stock quote shares HIMS – Hims & Hers Health, Inc. Stock Price stock today

news today HIMS – Hims & Hers Health, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch HIMS – Hims & Hers Health, Inc. yahoo finance google finance

stock history HIMS – Hims & Hers Health, Inc. invest stock market

stock prices HIMS premarket after hours

ticker HIMS fair value insiders trading

SUPN – Supernus Pharmaceuticals Inc

SUPN — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

3.82

Margin Of Safety %

Put/Call OI Ratio

0.99

EPS Next Q Diff

-0.49

EPS Last/This Y

4.37

EPS This/Next Y

0.31

Price

29.72

Target Price

45.67

Analyst Recom

1.33

Performance Q

-1.99

Upside

325.1%

Beta

-0.58

Ticker: SUPN

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-15	SUPN	39.56	4.28	1.00	1839
2026-10-16	SUPN	37.87	4.32	1.52	1841
2026-10-19	SUPN	39.81	3.85	0.00	1772
2026-10-20	SUPN	41.15	3.83	999.99	1773
2026-10-21	SUPN	41.2	3.84	0.40	1775
2026-10-22	SUPN	42.08	3.84	0.40	1775
2026-10-23	SUPN	40.66	3.85	0.00	1775
2026-10-26	SUPN	40.78	3.85	0.00	1775
2026-10-27	SUPN	40.93	3.85	1.00	1775
2026-10-28	SUPN	41.15	3.85	0.50	1775
2026-10-29	SUPN	41.84	3.85	0.50	1775
2026-10-30	SUPN	41.94	3.84	0.00	1763
2026-11-02	SUPN	41.92	3.84	11.00	1763
2026-11-03	SUPN	28.15	3.77	0.20	1745
2026-11-04	SUPN	28.27	1.08	0.06	22565
2026-11-05	SUPN	26.76	1.04	14.00	23068
2026-11-06	SUPN	26.18	1.06	1.19	22911
2026-11-09	SUPN	27.62	1.06	0.19	22877
2026-11-10	SUPN	28.77	1.06	0.01	22898
2026-11-11	SUPN	29.45	1.00	0.16	23621
2026-11-12	SUPN	29.21	0.99	0.14	23693
2026-11-13	SUPN	29.72	0.99	0.04	23679
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-15	SUPN	39.55	1.2	-	2.56
2026-10-16	SUPN	37.85	1.2	-	2.56
2026-10-19	SUPN	39.78	1.2	-	2.56
2026-10-20	SUPN	39.78	1.2	-	2.56
2026-10-21	SUPN	41.22	-8.7	-	2.54
2026-10-22	SUPN	42.08	-8.7	-	2.54
2026-10-23	SUPN	40.67	-8.7	-	2.54
2026-10-26	SUPN	40.78	-19.4	-	2.38
2026-10-27	SUPN	40.93	-19.4	-	2.38
2026-10-28	SUPN	41.15	-19.4	-	2.38
2026-10-29	SUPN	41.85	-19.4	-	2.38
2026-10-30	SUPN	41.95	-19.4	-	2.38
2026-11-02	SUPN	41.94	-19.4	-	2.38
2026-11-03	SUPN	28.19	17.3	-	2.77
2026-11-04	SUPN	28.27	17.3	-	2.77
2026-11-05	SUPN	26.77	17.3	-	2.77
2026-11-06	SUPN	26.17	48.8	-	4.42
2026-11-09	SUPN	27.63	48.8	-	4.42
2026-11-10	SUPN	28.75	48.8	-	3.44
2026-11-11	SUPN	29.42	48.8	-	3.44
2026-11-12	SUPN	29.20	25.6	-	3.69
2026-11-13	SUPN	29.72	25.6	-	3.69
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-15	SUPN	0.00	1.52	9.14
2026-10-16	SUPN	0.00	1.52	9.14
2026-10-19	SUPN	0.00	1.45	9.14
2026-10-20	SUPN	0.00	1.45	9.14
2026-10-21	SUPN	0.00	1.45	9.14
2026-10-22	SUPN	0.00	1.45	9.14
2026-10-23	SUPN	0.00	1.45	9.14
2026-10-26	SUPN	0.00	2.16	9.14
2026-10-27	SUPN	0.00	2.16	7.42
2026-10-28	SUPN	0.00	2.16	7.42
2026-10-29	SUPN	0.00	2.16	7.42
2026-10-30	SUPN	0.00	2.16	7.42
2026-11-02	SUPN	0.00	2.29	7.41
2026-11-03	SUPN	0.00	2.29	3.34
2026-11-05	SUPN	0.00	2.29	3.34
2026-11-06	SUPN	0.00	2.29	3.34
2026-11-09	SUPN	0.00	-4.51	3.34
2026-11-10	SUPN	0.00	-4.51	3.34
2026-11-11	SUPN	0.00	-4.51	3.82
2026-11-12	SUPN	0.00	-4.51	3.82
2026-11-13	SUPN	0.00	-4.51	3.82
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

1.32

Avg. EPS Est. Current Quarter

1.03

Avg. EPS Est. Next Quarter

0.83

Insider Transactions

Institutional Transactions

-4.51

Beta

-0.58

Average Sales Estimate Current Quarter

371

Average Sales Estimate Next Quarter

392

Fair Value

34.37

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

50.2

Max Drawdown 5-Year %

-54.1

Target Price

45.67

P/E

8.23

Forward P/E

7.65

PEG

0.37

P/S

4.49

P/B

P/Free Cash Flow

237.81

EPS

3.61

Average EPS Est. Cur. Y

3.69

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

32.75

Relative Volume

0.62

Return on Equity vs Sector %

-30.5

Return on Equity vs Industry %

-10.8

EPS 1 7Days Diff

-0.7

EPS 1 30Days Diff

-0.72

EBIT Estimation

◆ SUPN Healthcare

$29.72

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

12/25

Volume

6/15

Valuation

18/20

TP/AR

2/10

Options

2/10

RSI

63.6

Range 1M

34.4%

Sup Dist

3.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

2/25

Growth

24/30

Estimates

4/20

Inst/Vol

1/15

Options

4/10

EPS Yr

23.5%

EPS NY

25.8%

52W%

22.6%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +201% upside

Quality

8/30

Valuation

25/30

Growth

20/25

Stability

6/10

LT Trend

1/5

Upside

+201%

Quality

MoS

16%

SUPN — P/E HistoricalDrug Manufacturers - Specialty & Generic

Supernus, Inc.

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 827

Supernus, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. It develops medicines to treat substance use disorders. The company's core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; and SUBOXONE Film, a buprenorphine and naloxone sublingual film. It also manufactures SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). In addition, the company is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. Supernus, Inc. was formerly known as Indivior Pharmaceuticals, Inc. and changed its name Supernus, Inc. in November 2026. Supernus, Inc. was incorporated in 2014 and is headquartered in Rockville, Maryland.

SUPN

Latest News

—

Caricamento notizie per SUPN…

stock quote shares SUPN – Supernus Pharmaceuticals Inc Stock Price stock today

news today SUPN – Supernus Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch SUPN – Supernus Pharmaceuticals Inc yahoo finance google finance

stock history SUPN – Supernus Pharmaceuticals Inc invest stock market

stock prices SUPN premarket after hours

ticker SUPN fair value insiders trading

OGI – OrganiGram Holdings Inc.

OGI — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

5.47

Margin Of Safety %

Put/Call OI Ratio

0.11

EPS Next Q Diff

0.06

EPS Last/This Y

0.58

EPS This/Next Y

-0.42

Price

0.83

Target Price

2.28

Analyst Recom

Performance Q

-32.36

Upside

604.8%

Beta

1.55

Ticker: OGI

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-15	OGI	0.9328	0.14	0.00	10148
2026-10-16	OGI	0.9267	0.14	2.82	10154
2026-10-19	OGI	0.9439	0.13	0.03	9909
2026-10-20	OGI	0.9377	0.13	0.27	9932
2026-10-21	OGI	0.939	0.14	0.01	10295
2026-10-22	OGI	0.9409	0.12	0.00	11342
2026-10-23	OGI	0.9326	0.12	0.00	11342
2026-10-26	OGI	0.9391	0.12	999.99	11338
2026-10-27	OGI	0.9395	0.12	999.99	11338
2026-10-28	OGI	0.9558	0.12	0.00	11342
2026-10-29	OGI	0.967	0.12	0.01	11390
2026-10-30	OGI	0.9444	0.12	0.00	11451
2026-11-02	OGI	0.9698	0.11	0.00	12299
2026-11-03	OGI	0.9158	0.11	0.00	12359
2026-11-04	OGI	0.9632	0.11	0.00	13109
2026-11-05	OGI	0.9299	0.10	0.00	13206
2026-11-06	OGI	0.8778	0.11	1.43	12554
2026-11-09	OGI	0.873	0.11	0.00	12578
2026-11-10	OGI	0.8523	0.11	0.04	12637
2026-11-11	OGI	0.8501	0.11	0.07	12823
2026-11-12	OGI	0.8343	0.11	0.00	12806
2026-11-13	OGI	0.828	0.11	0.01	12912
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-15	OGI	0.93	-	-	0.44
2026-10-16	OGI	0.93	-	-	0.44
2026-10-19	OGI	0.94	-	-	0.44
2026-10-20	OGI	0.94	-	-	0.44
2026-10-21	OGI	0.94	-	-	0.44
2026-10-22	OGI	0.94	-	-	0.44
2026-10-23	OGI	0.93	-	-	0.44
2026-10-26	OGI	0.94	-	-	0.44
2026-10-27	OGI	0.94	-	-	0.44
2026-10-28	OGI	0.96	-	-	0.44
2026-10-29	OGI	0.96	-	-	0.44
2026-10-30	OGI	0.94	-	-	0.44
2026-11-02	OGI	0.97	-	-	0.44
2026-11-03	OGI	0.92	-	-	0.44
2026-11-04	OGI	0.96	-	-	0.44
2026-11-05	OGI	0.93	-	-	0.44
2026-11-06	OGI	0.88	-	-	0.44
2026-11-09	OGI	0.87	-	-	0.44
2026-11-10	OGI	0.85	-	-	0.44
2026-11-11	OGI	0.85	-	-	0.44
2026-11-12	OGI	0.83	-	-	0.44
2026-11-13	OGI	0.83	-	-	0.44
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-15	OGI	0.00	-0.24	4.63
2026-10-16	OGI	0.00	-0.24	4.63
2026-10-19	OGI	0.00	-0.25	4.63
2026-10-20	OGI	0.00	-0.25	4.63
2026-10-21	OGI	0.00	-0.25	4.63
2026-10-22	OGI	0.00	-0.25	4.63
2026-10-23	OGI	0.00	-0.25	4.63
2026-10-26	OGI	0.00	-0.19	4.63
2026-10-27	OGI	0.00	-0.19	4.96
2026-10-28	OGI	0.00	-0.19	4.96
2026-10-29	OGI	0.00	-0.19	4.96
2026-10-30	OGI	0.00	-0.19	4.96
2026-11-02	OGI	0.00	-0.20	4.96
2026-11-03	OGI	0.00	-0.20	4.96
2026-11-05	OGI	0.00	-0.20	4.96
2026-11-06	OGI	0.00	-0.20	4.96
2026-11-09	OGI	0.00	-0.20	4.96
2026-11-10	OGI	0.00	-0.20	4.96
2026-11-11	OGI	0.00	-0.20	5.47
2026-11-12	OGI	0.00	-0.20	5.47
2026-11-13	OGI	0.00	-0.20	5.47
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.05

Avg. EPS Est. Current Quarter

0.01

Avg. EPS Est. Next Quarter

0.01

Insider Transactions

Institutional Transactions

-0.2

Beta

1.55

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

91.9

Max Drawdown 5-Year %

-91.2

Target Price

2.28

P/E

1.83

Forward P/E

14.5

PEG

P/S

0.52

P/B

0.34

P/Free Cash Flow

EPS

0.45

Average EPS Est. Cur. Y

0.44

EPS Next Y. (Est.)

0.02

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

27.86

Relative Volume

0.72

Return on Equity vs Sector %

-8.6

Return on Equity vs Industry %

11.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ OGI Healthcare

$0.83

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

23/25

Volume

9/15

Valuation

15/20

TP/AR

2/10

Options

8/10

RSI

31.1

Range 1M

13.9%

Sup Dist

1.4%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

8/25

Growth

19/30

Estimates

4/20

Inst/Vol

0/15

Options

8/10

EPS Yr

531.7%

EPS NY

-90.2%

52W%

1.7%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +0.8% upside

Quality

10/30

Valuation

4/30

Growth

11/25

Stability

6/10

LT Trend

4/5

Upside

+0.8%

Quality

OGI — P/E HistoricalDrug Manufacturers - Specialty & Generic

Organigram Global Inc.

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 1139

Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online. Organigram Global Inc. was formerly known as Organigram Holdings Inc. and changed its name to Organigram Global Inc. in March 2025. The company is headquartered in Toronto, Canada.

OGI

Latest News

—

Caricamento notizie per OGI…

stock quote shares OGI – OrganiGram Holdings Inc. Stock Price stock today

news today OGI – OrganiGram Holdings Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch OGI – OrganiGram Holdings Inc. yahoo finance google finance

stock history OGI – OrganiGram Holdings Inc. invest stock market

stock prices OGI premarket after hours

ticker OGI fair value insiders trading

MURA – Mural Oncology plc

MURA — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

2.66

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

2.04

Target Price

Analyst Recom

Performance Q

-1.45

Upside

N/A

Beta

2.88

Ticker: MURA

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-15	MURA	2.04	N/A	N/A	0
2026-10-16	MURA	2.04	N/A	N/A	0
2026-10-19	MURA	2.04	N/A	N/A	0
2026-10-20	MURA	2.04	N/A	N/A	0
2026-10-21	MURA	2.04	N/A	N/A	0
2026-10-22	MURA	2.04	N/A	N/A	0
2026-10-23	MURA	2.04	N/A	N/A	0
2026-10-26	MURA	2.04	N/A	N/A	0
2026-10-27	MURA	2.04	N/A	N/A	0
2026-10-28	MURA	2.04	N/A	N/A	0
2026-10-29	MURA	2.04	N/A	N/A	0
2026-10-30	MURA	2.04	N/A	N/A	0
2026-11-02	MURA	2.04	N/A	N/A	0
2026-11-03	MURA	2.04	N/A	N/A	0
2026-11-04	MURA	2.04	N/A	N/A	0
2026-11-05	MURA	2.04	N/A	N/A	0
2026-11-06	MURA	2.04	N/A	N/A	0
2026-11-09	MURA	2.04	N/A	N/A	0
2026-11-10	MURA	2.04	N/A	N/A	0
2026-11-11	MURA	2.04	N/A	N/A	0
2026-11-12	MURA	2.04	N/A	N/A	0
2026-11-13	MURA	2.04	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

Last Quarter Act. EPS

-0.21

Avg. EPS Est. Current Quarter

-0.37

Avg. EPS Est. Next Quarter

Insider Transactions

-2.62

Institutional Transactions

-16.45

Beta

2.88

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

0.64

P/Free Cash Flow

EPS

-6.93

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

-0.39

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

-242.8

Return on Equity vs Industry %

-227.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

No data found for MURA

MURA — P/E HistoricalDrug Manufacturers - Specialty & Generic

Sector:

Industry:

Employees:

MURA

Latest News

—

Caricamento notizie per MURA…

stock quote shares MURA – Mural Oncology plc Stock Price stock today

news today MURA – Mural Oncology plc stock forecast ,stock prediction 2023 2024 2025

marketwatch MURA – Mural Oncology plc yahoo finance google finance

stock history MURA – Mural Oncology plc invest stock market

stock prices MURA premarket after hours

ticker MURA fair value insiders trading

EVOK – Evoke Pharma Inc

EVOK — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.73

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

2.56

Price

Target Price

Analyst Recom

Performance Q

116.11

Upside

N/A

Beta

-0.1

Ticker: EVOK

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-15	EVOK	11	N/A	N/A	0
2026-10-16	EVOK	11	N/A	N/A	0
2026-10-19	EVOK	11	N/A	N/A	0
2026-10-20	EVOK	11	N/A	N/A	0
2026-10-21	EVOK	11	N/A	N/A	0
2026-10-22	EVOK	11	N/A	N/A	0
2026-10-23	EVOK	11	N/A	N/A	0
2026-10-26	EVOK	11	N/A	N/A	0
2026-10-27	EVOK	11	N/A	N/A	0
2026-10-28	EVOK	11	N/A	N/A	0
2026-10-29	EVOK	11	N/A	N/A	0
2026-10-30	EVOK	11	N/A	N/A	0
2026-11-02	EVOK	11	N/A	N/A	0
2026-11-03	EVOK	11	N/A	N/A	0
2026-11-04	EVOK	11	N/A	N/A	0
2026-11-05	EVOK	11	N/A	N/A	0
2026-11-06	EVOK	11	N/A	N/A	0
2026-11-09	EVOK	11	N/A	N/A	0
2026-11-10	EVOK	11	N/A	N/A	0
2026-11-11	EVOK	11	N/A	N/A	0
2026-11-12	EVOK	11	N/A	N/A	0
2026-11-13	EVOK	11	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-0.3

Avg. EPS Est. Next Quarter

Insider Transactions

-3.69

Institutional Transactions

Beta

-0.1

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

98.4

Max Drawdown 5-Year %

-99.7

Target Price

P/E

Forward P/E

PEG

P/S

1.31

P/B

5.64

P/Free Cash Flow

EPS

-2.38

Average EPS Est. Cur. Y

-1.88

EPS Next Y. (Est.)

0.68

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-36.23

Relative Volume

Return on Equity vs Sector %

-166.4

Return on Equity vs Industry %

-162.7

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.08

EBIT Estimation

No data found for EVOK

EVOK — P/E HistoricalDrug Manufacturers - Specialty & Generic

Sector:

Industry:

Employees:

EVOK

Latest News

—

Caricamento notizie per EVOK…

stock quote shares EVOK – Evoke Pharma Inc Stock Price stock today

news today EVOK – Evoke Pharma Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch EVOK – Evoke Pharma Inc yahoo finance google finance

stock history EVOK – Evoke Pharma Inc invest stock market

stock prices EVOK premarket after hours

ticker EVOK fair value insiders trading

AMPH – Amphastar Pharmaceuticals Inc

AMPH — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

13.75

Margin Of Safety %

Put/Call OI Ratio

0.43

EPS Next Q Diff

-0.29

EPS Last/This Y

-0.09

EPS This/Next Y

-0.52

Price

29.36

Target Price

24.5

Analyst Recom

3.14

Performance Q

40.8

Upside

-2.2%

Beta

0.94

Ticker: AMPH

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-15	AMPH	26.41	0.06	0.05	2135
2026-10-16	AMPH	25.84	0.06	0.15	2073
2026-10-19	AMPH	26.11	0.42	0.50	384
2026-10-20	AMPH	25.93	0.41	4.00	387
2026-10-21	AMPH	26.22	0.39	0.57	386
2026-10-22	AMPH	26.03	0.39	0.57	386
2026-10-23	AMPH	25.14	0.39	0.57	386
2026-10-26	AMPH	25.44	0.40	0.00	392
2026-10-27	AMPH	25.59	0.42	0.00	374
2026-10-28	AMPH	26.33	0.41	0.33	380
2026-10-29	AMPH	26.94	0.41	0.67	383
2026-10-30	AMPH	27.73	0.41	0.08	383
2026-11-02	AMPH	27.11	0.40	0.08	390
2026-11-03	AMPH	27.22	0.40	1.00	399
2026-11-04	AMPH	28.03	0.40	0.00	402
2026-11-05	AMPH	27.7	0.40	0.67	404
2026-11-06	AMPH	28.47	0.43	0.08	416
2026-11-09	AMPH	29.38	0.44	0.05	412
2026-11-10	AMPH	29.05	0.42	0.00	426
2026-11-11	AMPH	28.6	0.43	0.17	419
2026-11-12	AMPH	28.84	0.43	0.00	419
2026-11-13	AMPH	29.38	0.43	0.80	418
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-15	AMPH	26.42	-7.0	-	2.97
2026-10-16	AMPH	25.84	-7.0	-	2.97
2026-10-19	AMPH	26.13	-7.0	-	2.97
2026-10-20	AMPH	26.13	-7.0	-	2.97
2026-10-21	AMPH	25.96	-7.0	-	2.97
2026-10-22	AMPH	26.03	-7.0	-	2.97
2026-10-23	AMPH	25.14	-7.0	-	2.97
2026-10-26	AMPH	25.49	-7.7	-	2.96
2026-10-27	AMPH	25.57	-7.7	-	2.96
2026-10-28	AMPH	26.34	-7.7	-	2.96
2026-10-29	AMPH	26.93	-7.7	-	2.96
2026-10-30	AMPH	27.74	-7.7	-	2.96
2026-11-02	AMPH	27.10	-7.7	-	2.96
2026-11-03	AMPH	27.13	-7.7	-	2.96
2026-11-04	AMPH	28.04	-7.7	-	2.96
2026-11-05	AMPH	27.66	-7.7	-	2.96
2026-11-06	AMPH	28.50	-7.7	-	2.96
2026-11-09	AMPH	29.39	8.8	-	2.96
2026-11-10	AMPH	29.09	8.8	-	2.96
2026-11-11	AMPH	28.61	8.8	-	3.16
2026-11-12	AMPH	28.86	8.8	-	3.16
2026-11-13	AMPH	29.36	6.3	-	3.16
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-15	AMPH	-0.29	-9.59	14.25
2026-10-16	AMPH	-0.29	-9.59	14.25
2026-10-19	AMPH	-0.29	-9.58	14.25
2026-10-20	AMPH	-0.29	-9.58	14.25
2026-10-21	AMPH	-0.29	-9.58	14.25
2026-10-22	AMPH	-0.29	-9.58	14.25
2026-10-23	AMPH	-0.29	-9.58	14.25
2026-10-26	AMPH	-0.29	-9.68	14.25
2026-10-27	AMPH	-0.29	-9.68	14.02
2026-10-28	AMPH	-0.29	-9.68	14.02
2026-10-29	AMPH	-0.29	-9.68	14.02
2026-10-30	AMPH	-0.29	-9.68	14.02
2026-11-02	AMPH	-0.29	-9.64	14.02
2026-11-03	AMPH	-0.29	-9.64	14.02
2026-11-05	AMPH	-0.29	-9.64	14.02
2026-11-06	AMPH	-0.29	-9.64	14.02
2026-11-09	AMPH	-0.53	-9.86	13.98
2026-11-10	AMPH	-0.53	-9.86	13.98
2026-11-11	AMPH	-0.53	-9.86	13.75
2026-11-12	AMPH	-0.53	-9.86	13.75
2026-11-13	AMPH	-0.53	-9.86	13.75
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

1.01

Avg. EPS Est. Current Quarter

0.69

Avg. EPS Est. Next Quarter

0.72

Insider Transactions

-0.53

Institutional Transactions

-9.86

Beta

0.94

Average Sales Estimate Current Quarter

196

Average Sales Estimate Next Quarter

186

Fair Value

32.17

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

56.6

Max Drawdown 5-Year %

-74

Target Price

24.5

P/E

13.27

Forward P/E

8.76

PEG

2.74

P/S

1.68

P/B

1.54

P/Free Cash Flow

9.01

EPS

2.21

Average EPS Est. Cur. Y

3.16

EPS Next Y. (Est.)

2.64

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

13.27

Relative Volume

0.81

Return on Equity vs Sector %

-14.3

Return on Equity vs Industry %

5.4

EPS 1 7Days Diff

0.2

EPS 1 30Days Diff

0.18

EBIT Estimation

◆ AMPH Healthcare

$29.37

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

20/20

Pullback

6/25

Volume

7/15

Valuation

10/20

TP/AR

1/10

Options

6/10

RSI

67.2

Range 1M

75.4%

Sup Dist

2.7%

🚀

Momentum Growth

Ride accelerating trends

WEAK

Momentum

25/25

Growth

12/30

Estimates

7/20

Inst/Vol

4/15

Options

6/10

EPS Yr

-1.6%

EPS NY

4.9%

52W%

89.1%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟡 HOLD +8% upside

Quality

9/30

Valuation

8/30

Growth

11/25

Stability

5/10

LT Trend

4/5

Upside

+8%

Quality

MoS

10%

AMPH — P/E HistoricalDrug Manufacturers - Specialty & Generic

Amphastar Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 1976

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a dry nasal spray used in an emergency for the treatment of severe hypoglycemia; Primatene MIST, an epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Glucagon for injection emergency kit; Enoxaparin, an injectable form of low molecular weight heparin for the prevention and treatment of deep vein thrombosis; and REXTOVY and Naloxone for opioid overdose. The company also provides Cortrosyn, a lyophilized power for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency; Amphadase, a bovine-sourced hyaluronidase injection; Epinephrine injection for allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; and emergency syringe products, including atropine, calcium chloride, dextrose, epinephrine, lidocaine, and sodium bicarbonate. In addition, it offers Albuterol sulfate inhalation aerosol for the treatment or prevention of bronchospasm; Iron sucrose injection, an iron replacement product for the treatment of iron deficiency anemia in patients with chronic kidney disease; Teriparatide injection for managing daily osteoporosis therapy; and Ipratropium Bromide HFA inhalation aerosol, an anticholinergic indicated for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease. Further, the company provides active pharmaceutical ingredient (API) products, such as Recombinant Human Insulin and porcine insulin API. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

AMPH

Latest News

—

Caricamento notizie per AMPH…

stock quote shares AMPH – Amphastar Pharmaceuticals Inc Stock Price stock today

news today AMPH – Amphastar Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch AMPH – Amphastar Pharmaceuticals Inc yahoo finance google finance

stock history AMPH – Amphastar Pharmaceuticals Inc invest stock market

stock prices AMPH premarket after hours

ticker AMPH fair value insiders trading

No more stocks to show

HIMS – Hims & Hers Health, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: HIMS

No data found

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

SUPN – Supernus Pharmaceuticals Inc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SUPN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y